121 related articles for article (PubMed ID: 38048725)
21. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
Llamas-Olier AE; Cuéllar DI; Buitrago G
Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
[TBL] [Abstract][Full Text] [Related]
22. Staged Surgery for Advanced Thyroid Cancers: Safety and Oncologic Outcomes of Neural Monitored Surgery.
Salari B; Hammon RJ; Kamani D; Randolph GW
Otolaryngol Head Neck Surg; 2017 May; 156(5):816-821. PubMed ID: 28374646
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies.
Adhikari LJ; Sciallis AP; Reynolds J; Jenkins S; Smith C; Stan MN; Nassar A
Thyroid; 2013 Aug; 23(8):982-8. PubMed ID: 23374006
[TBL] [Abstract][Full Text] [Related]
24. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
[TBL] [Abstract][Full Text] [Related]
25. Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values.
Kloos RT
J Clin Endocrinol Metab; 2010 Dec; 95(12):5241-8. PubMed ID: 20843945
[TBL] [Abstract][Full Text] [Related]
26. The first postoperative-stimulated serum thyroglobulin is a prognostic factor for thyroid microcarcinomas.
Amui IO; Tagliarini JV; Castilho EC; Marques MA; Kiy Y; Corrente JE; Mazeto GMFS
Braz J Otorhinolaryngol; 2019; 85(1):37-42. PubMed ID: 29157630
[TBL] [Abstract][Full Text] [Related]
27. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas.
Zhao L; Gong Y; Wang J; Dawlett M; Huo L; Caraway NP; Guo M
Cancer Cytopathol; 2013 Feb; 121(2):101-7. PubMed ID: 22605565
[TBL] [Abstract][Full Text] [Related]
29. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary.
Domínguez JM; Nilo F; Contreras T; Carmona R; Droppelmann N; González H; Iturrieta V; Tuttle RM
J Ultrasound Med; 2017 Nov; 36(11):2299-2307. PubMed ID: 28543974
[TBL] [Abstract][Full Text] [Related]
30. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
31. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
32. Lobectomy versus total thyroidectomy in children with post-Chernobyl thyroid cancer: a 15 year follow-up.
Antonelli A; Fallahi P; Grosso M; Boni G; Minuto MN; Miccoli P
Endocrine; 2011 Dec; 40(3):432-6. PubMed ID: 21698517
[TBL] [Abstract][Full Text] [Related]
33. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
34. Thyroglobulin - what is the postoperative threshold for the suspicion of thyroid cancer recurrence in the absence of anti-Tg antibody measurement?
Papageorgiou MS; Liratzopoulos N; Minopoulos G; Manolas KJ
S Afr J Surg; 2011 Aug; 49(3):118-22. PubMed ID: 21933495
[TBL] [Abstract][Full Text] [Related]
35. Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma.
Orlov S; Orlov D; Shaytzag M; Dowar M; Tabatabaie V; Dwek P; Yip J; Hu C; Freeman JL; Walfish PG
Head Neck; 2009 Jun; 31(6):782-8. PubMed ID: 19260133
[TBL] [Abstract][Full Text] [Related]
36. Excision efficiency of radioguided occult lesion localization in reoperative thyroid and parathyroid surgery.
Terzioğlu T; Senyurek YG; Tunca F; Türkmen C; Mudun A; Salmaslıoglu A; Sanlı S; Bircan H; Demirkol O; Tezelman S
Thyroid; 2010 Nov; 20(11):1271-8. PubMed ID: 20950253
[TBL] [Abstract][Full Text] [Related]
37. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
Ritter A; Mizrachi A; Bachar G; Vainer I; Shimon I; Hirsch D; Diker-Cohen T; Duskin-Bitan H; Robenshtok E
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219303
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
[TBL] [Abstract][Full Text] [Related]
39. Cut-off value for needle washout thyroglobulin in athyrotropic patients.
Lee YH; Seo HS; Suh SI; Lee NJ; Kim JH; Seol HY; Lee JH; Kwon SY; Kim NH; Seo JA; Yang KS
Laryngoscope; 2010 Jun; 120(6):1120-4. PubMed ID: 20513027
[TBL] [Abstract][Full Text] [Related]
40. Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans.
Küçük ON; Aras G; Kulak HA; Ibiş E
Nucl Med Commun; 2006 Nov; 27(11):873-6. PubMed ID: 17021427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
